NOX2 inhibition by GSK2795039 effectively prevented endothelial dysfunction as well as oxidative stress induced by sortilin, whereas these effects were not observed with the NOX1 inhibitor ML171 (Figure 3, C and D). The gene discussed is CYBB; the disease is endothelial dysfunction.